Global Arrhythmia Market Size - Forecasts to 2026

Global Arrhythmia Market Size - Forecasts to 2026

According to a new market research report published by Global Market Estimates, the Global Arrhythmia Market will expand with a CAGR value of 6.2% from 2021 to 2026. Determinants such as the growing number of instances of lifestyle practices such as smoking and excessive alcohol consumption being adopted, increasing occurrences of obesity, which ultimately makes a body more susceptive to cardiac arrhythmias, and the rising levels of awareness in patients, globally are driving the growth of the arrhythmia market.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Arrhythmia Market - Forecast to 2026"

By Type (Extra Beats [Premature Arterial Contractions, Premature Ventricular Contractions], Ventricular Arrhythmias [Ventricular Fibrillation, Ventricular Tachycardia], Supraventricular Tachycardias [Ventricular Fibrillation, Ventricular Tachycardia], Bradyarrhythmia), By Test Equipment (Holter Monitor, Electrocardiogram (ECG)), By Site of Origin (Premature Atrial Contractions (PACS), Sinus Bradycardia, Atrial Tachycardia, Wandering Atrial Pacemaker, Supraventricular Tachycardia (SVT), Multifocal Atrial Tachycardia, Atrial Fibrillation (AFIB), Atrial Flutter), By Heart Blocks (First Degree Heart Block, Second Degree Heart Block [Type 1 Or Mobitz I, Type 2 Or Mobitz II], Third Degree Heart Block), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

Key Market Insights

  • One in eighteen people or about five percent of the US population suffers from arrythmia. The growing number of arrythmia patients and the excellent health care facilities has resulted in the North American market dominating the arrythmia market
  • The extra beats segment will hold a significant market share as per the type of arrythmia analysis
  • The electrocardiogram (ECG) segment will hold the largest market share when the market is segmented on the basis of the different types of test equipment available
  • Medtronic, NUUBO Smart Solutions Technologies, Teva Pharmaceutical Industries, Abbott Laboratories (St. Jude Medical), Mayne Pharma, Fukuda Denshi, Nihon Kohden, GlaxoSmithKline LLC, Philips Healthcare, Sanofi S.A., Upsher-Smith Laboratories LLC, Hill-Rom (Welch Allyn), Novartis International AG, BioTelemetry, Biotronik, GE Healthcare, OSI Systems (Spacelabs Healthcare), Mylan N.V., are some of the key players in the arrhythmia market

Browse the Report @

Type Outlook (Revenue, USD Billion, 2021-2026)

  • Extra Beats
  • Premature Arterial Contractions
  • Premature Ventricular Contractions
  • Ventricular Arrhythmias
  • Ventricular Fibrillation
  • Ventricular Tachycardia
  • Supraventricular Tachycardias
  • Ventricular Fibrillation
  • Ventricular Tachycardia
  • Bradyarrhythmia

Test Equipment Outlook (Revenue, USD Billion, 2021-2026)

  • Holter Monitor
  • Electrocardiogram (ECG)

Site of Origin Outlook (Revenue, USD Billion, 2021-2026)

  • Premature Atrial Contractions (PACS)
  • Sinus Bradycardia
  • Atrial Tachycardia
  • Wandering Atrial Pacemaker
  • Supraventricular Tachycardia (SVT)
  • Multifocal Atrial Tachycardia
  • Atrial Fibrillation (AFIB)
  • Atrial Flutter

Heart Blocks Outlook (Revenue, USD Billion, 2021-2026)

  • First Degree Heart Block
  • Second Degree Heart Block
  • Type 1 Or Mobitz I
  • Type 2 Or Mobitz II
  • Third Degree Heart Block

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America

  • The U.S.
  • Canada
  • Mexico


  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Central & South America

  • Brazil
  • Argentina
  • Rest of CSA

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Rest of MEA

Contact: Yash Jain

Email address:

Phone Number: +16026667238


Check our Latest Blogs: